Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15601 - 15625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	XIAP	331	upregulated	Bortezomib results in increased expression of XIAP mRNA	Xq25	A21434
Bortezomib	Approved Investigational	XPNPEP3	63929	downregulated	Bortezomib results in decreased expression of XPNPEP3 mRNA	22q13.2	A21434
Bortezomib	Approved Investigational	XPO5	57510	downregulated	Bortezomib results in decreased expression of XPO5 mRNA	6p21.1	A21434
Bortezomib	Approved Investigational	XRCC3	7517	downregulated	Bortezomib results in decreased expression of XRCC3 mRNA	14q32.3	A21434
Bortezomib	Approved Investigational	XXYLT1	152002	downregulated	Bortezomib results in decreased expression of XXYLT1 mRNA	3q29	A21434
Bortezomib	Approved Investigational	YES1	7525	upregulated	Bortezomib results in increased expression of YES1 mRNA	18p11.32	A21434
Bortezomib	Approved Investigational	YPEL5	51646	upregulated	Bortezomib results in increased expression of YPEL5 mRNA	2p23.1	A21434
Bortezomib	Approved Investigational	YWHAE	7531	downregulated	Bortezomib results in decreased expression of YWHAE mRNA	17p13.3	A21434
Bortezomib	Approved Investigational	YWHAZ	7534	upregulated	Bortezomib results in increased expression of YWHAZ mRNA	8q22.3	A21434
Bortezomib	Approved Investigational	ZBTB3	79842	upregulated	Bortezomib results in increased expression of ZBTB3 mRNA	11q12.3	A21434
Bortezomib	Approved Investigational	ZCCHC2	54877	upregulated	Bortezomib results in increased expression of ZCCHC2 mRNA	18q21.33	A21434
Bortezomib	Approved Investigational	ZFAND2A	90637	upregulated	Bortezomib results in increased expression of ZFAND2A mRNA	7p22.3	A21434
Bortezomib	Approved Investigational	ZFPM1	161882	downregulated	Bortezomib results in decreased expression of ZFPM1 mRNA	16q24.2	A21434
Bortezomib	Approved Investigational	ZFX	7543	upregulated	Bortezomib results in increased expression of ZFX mRNA	Xp22.11	A21434
Bortezomib	Approved Investigational	ZGPAT	84619	upregulated	Bortezomib results in increased expression of ZGPAT mRNA	20q13.33	A21434
Bortezomib	Approved Investigational	ZMYND11	10771	downregulated	Bortezomib results in decreased expression of ZMYND11 mRNA	10p15.3	A21434
Bortezomib	Approved Investigational	ZMYND8	23613	downregulated	Bortezomib results in decreased expression of ZMYND8 mRNA	20q13.12	A21434
Bortezomib	Approved Investigational	ZNF165	7718	upregulated	Bortezomib results in increased expression of ZNF165 mRNA	6p22.1	A21434
Bortezomib	Approved Investigational	ZNF23	7571	upregulated	Bortezomib results in increased expression of ZNF23 mRNA	16q22.2	A21434
Bortezomib	Approved Investigational	ZNF335	63925	downregulated	Bortezomib results in decreased expression of ZNF335 mRNA	20q13.12	A21434
Bortezomib	Approved Investigational	ZNF580	51157	downregulated	Bortezomib results in decreased expression of ZNF580 mRNA	19q13.42	A21434
Bortezomib	Approved Investigational	ZNF613	79898	upregulated	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of ZNF613 mRNA	19q13.41	A21436
Bortezomib	Approved Investigational	ZNF768	79724	downregulated	Bortezomib results in decreased expression of ZNF768 mRNA	16p11.2	A21434
Bortezomib	Approved Investigational	ZNF787	126208	upregulated	Bortezomib results in increased expression of ZNF787 mRNA	19q13.43	A21434
Bortezomib	Approved Investigational	ZNF92	168374	upregulated	Bortezomib results in increased expression of ZNF92 mRNA	7q11.21	A21434

Displaying entries 15601 - 15625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability